Offer - Urjas Oil for just ₹ 1 X
Ltinea is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Ltinea safe for pregnant women?
The effects of Ltinea on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Ltinea safe during breastfeeding?
In the absence of any scientific study about the side effects of Ltinea in breastfeeding women, information on safety of Ltinea is unavailable.
What is the effect of Ltinea on the Kidneys?
Ltinea is not harmful for kidneys.
What is the effect of Ltinea on the Liver?
Ltinea does not damage the liver.
What is the effect of Ltinea on the Heart?
Ltinea is completely safe for the heart.
Ltinea should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Ltinea unless your doctor advises you to do so -
Is this Ltinea habit forming or addictive?
Ltinea does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Ltinea as it does not make you drowsy.
Is it safe?
Yes, Ltinea is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Ltinea for mental disorders.
Interaction between Food and Ltinea
You can take Ltinea with food.
Interaction between Alcohol and Ltinea
No research has been done on this till date. Therefore, it is not known what the effect of taking Ltinea with alcohol will be.
Ltinea is a brand name of luliconazole and it comes in the form of a topical cream. It belongs to the class of drugs known as antifungal agents (azole class anti-infectives). It is a prescription drug that is used for the treatment of interdigital tinea pedis also known as athlete's foot (fungal infection) that affects the area between the toes. It is also used in the treatment of jock itch also known as tinea cruris (fungal infection of the skin) that affects the skin area around the genitals, buttocks, and inner thighs and ringworm also known as tinea corporis. Ltinea is effective against all of these fungal skin infections that are caused by Trichophyton rubrum and Epidermophyton floccosum.
No, Ltinea is a prescription drug, hence patient should seek doctors advice before using this medication by himself or herself.
No, Ltinea does not cause itching. It has not been reported by the patients who are using this drug. In fact, it helps in providing relief from itching in case of skin infections.
Yes, Ltinea is safe to use, if applied in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed which occurs rarely such as skin irritation or burning sensation, and contact dermatitis. Do not hesitate to inform your doctor if you are facing any of the above.
Ltinea contains luliconazole which is an antifungal agent that works by preventing the synthesis of ergosterol (a component of the cell membrane of fungi) through inhibition of an enzyme known as lanosterol demethylase. In the absence of ergosterol fungal cell wall is damaged that results in an increase in permeability of fungal cell wall this causes leakage of nutrients which kills the fungi. Ltinea is effective against fungi such as Trichophyton rubrum and Epidermophyton floccosum.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Luzu (luliconazole) Cream, 1%
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176